Compare RPC & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RPC | IART |
|---|---|---|
| Founded | 1992 | 1989 |
| Country | United States | United States |
| Employees | 267 | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 932.7M | 823.8M |
| IPO Year | N/A | 1996 |
| Metric | RPC | IART |
|---|---|---|
| Price | $8.72 | $13.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 7 |
| Target Price | $11.00 | ★ $14.33 |
| AVG Volume (30 Days) | 510.2K | ★ 954.1K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.96% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.82 | $4.39 |
| Revenue Next Year | $15.80 | $3.40 |
| P/E Ratio | $53.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.79 | $8.70 |
| 52 Week High | $9.32 | $16.42 |
| Indicator | RPC | IART |
|---|---|---|
| Relative Strength Index (RSI) | 70.48 | 72.93 |
| Support Level | $6.94 | $12.90 |
| Resistance Level | N/A | $14.38 |
| Average True Range (ATR) | 0.32 | 0.71 |
| MACD | 0.09 | 0.37 |
| Stochastic Oscillator | 89.78 | 89.60 |
Ridgepost Capital Inc, formelrly P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Its Revenue primarily comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.